Kolon TissueGene, Inc. (950160.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenKRW 16,390.00

From 52W high−88.27%

Volume411073.00

Market capKRW 1.33T

P/E (TTM)—

P/S (TTM)278.5x

Div yield—

Key dataSep 18, 2026

Open

KRW 16,390.00

From 52W high

−88.27%

Volume

411073.00

Market cap

KRW 1.33T

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−10.8x

P/E (TTM)

—

RSI (14)

30.5

MomentumView details →

1D Return

+2.52%

YTD Return

−79.94%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−10.8x

EV/Sales

271.6x

P/S (TTM)

278.5x

P/B (TTM)

6.5x

ProfitabilityView details →

Gross Margin

8.00%

Net Margin

−3811.18%

EBITDA Margin

−2526.79%

ROE (TTM)

−88.49%

ROA (TTM)

−35.20%

Asset Turnover

0.01x

GrowthView details →

Revenue YoY

−13.54%

EPS YoY

−98.36%

FCF YoY

+52.21%

Revenue CAGR 3Y

−18.31%

EPS CAGR 3Y

—

EBITDA YoY

−38.33%

MomentumView details →

1D Return

+2.52%

YTD Return

−79.94%

1Y Return

−64.59%

RSI (14)

30.5

vs 50D SMA

−40.87%

vs 200D SMA

−79.61%

Capital & dividendView details →

Debt/Equity

0.31x

Current Ratio

0.33x

Quick Ratio

0.33x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

4.76B

Net Income (TTM)

−181.53B

Op. CF (TTM)

−17.36B

Latest newsMore news →

No recent news for 950160.KQ.

Similar companies

Orum Therapeutics, Inc.475830.KQ OliX Pharmaceuticals,Inc226950.KQ Pharmicell Co., Ltd.005690.KS Onconic Therapeutics476060.KQ Voronoi, Inc.310210.KQ D&D Pharmatech347850.KQ Find similar companies →

Latest newsMore news →

No recent news for 950160.KQ.